News
Form 8.3 - Maitland Institutional Services Limited: Re RPS Group plc
Element Solutions Inc Announces Date for 2022 Third Quarter Earnings Release
Element Solutions Inc (NYSE:ESI) ("Element Solutions") announced today that it intends to release its 2022 third quarter financial results after the market close on Wednesday, October 26, 2022.
State Street Global Advisors and Barclays Quantitative Portfolio Strategy Announce Collaboration on Active Systematic Fixed Income Strategies
State Street Global Advisors, the asset management business of State Street Corporation (NYSE: STT), today announced a collaboration with Barclays’ Research business through which State Street
SunOpta Announces Strategic Sale of Its Sunflower & Roasted Snacks Business to Pacific Avenue Capital
SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a U.S.-based global pioneer fueling the future of sustainable, plant-based and fruit-based foods and beverages, today announced
Form 8.3 - The Vanguard Group, Inc.: Vistry Group plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
BitNile, Inc. to Launch Innovative Bitcoin Marketplace Platform Intended to Reimagine Cryptocurrency Transactions
BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or the “Company”), announced today that its subsidiary, BitNile, Inc. (“BNI”), has begun development of a
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced early data from a Phase 2/3 clinical trial (NCT05472038) evaluating the safety, tolerability, and immunogenicity of the
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
Essent Group Ltd. Schedules Third Quarter Earnings Conference Call for November 4, 2022
Essent Group Ltd. (NYSE: ESNT) today announced that it will hold a conference call on Friday, November 4, 2022, at 10:00 a.m. Eastern Time to discuss the Company’s third quarter 2022 results, which
Cryptology’s estimated NAV per share as of 12/10/2022 is €4.98
Clara Valera, New Investor Relations and Business Development Director at Fluidra
Fluidra, global leader in pool and wellness equipment and connected solutions, has appointed Clara Valera as new Investor Relations and Business Development Director, reporting directly to Xavier
EQS-News: Record: Over 7,500 participants from 140 countries at Europe's largest compliance conference / Novartis AG honored with 'ECEC Award 2022'
Rights and Issues Investment Trust PLC: Net Asset Value(s)